SynCardia Systems raises $14m

SynCardia Systems has raised $14 million. SynCardia is a company focused on advanced medical technology targeting the NYHA Class IV heart failure market.

ByAngela Sormani

17 December 2013•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs

SynCardia Systems raises $14m

Athyrium Capital Management